questionsmedicales.fr
Thérapeutique
Traitement médicamenteux
Voies d'administration de substances chimiques et des médicaments
Administration par voie topique
Administration par voie topique : Questions médicales fréquentes
Diagnostic
5
Dermatite
Diagnostic médical
Infection cutanée
Tests diagnostiques
Allergie
Réaction cutanée
Évaluation dermatologique
Lésions cutanées
Symptômes
5
Irritation cutanée
Symptômes
Infection virale
Symptômes
Réaction allergique
Symptômes
Prévention
5
Prévention
Infection cutanée
Mycose cutanée
Prévention
Irritation cutanée
Prévention
Traitements
5
Eczéma
Traitement topique
Infection cutanée
Antibiotiques
Mycose cutanée
Antifongiques
Irritation cutanée
Antihistaminiques
Brûlures
Traitement topique
Complications
5
Infection cutanée
Complications
Administration topique
Effets secondaires
Mycose cutanée
Complications
Facteurs de risque
5
Eczéma
Facteurs de risque
Infection cutanée
Humidité
Stress
Affections cutanées
Infection cutanée
Facteurs de risque
Irritation cutanée
Produits irritants
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Administration par voie topique : Questions médicales les plus fréquentes",
"headline": "Administration par voie topique : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Administration par voie topique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-09",
"dateModified": "2026-04-29",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Administration par voie topique"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Voies d'administration de substances chimiques et des médicaments",
"url": "https://questionsmedicales.fr/mesh/D004333",
"about": {
"@type": "MedicalCondition",
"name": "Voies d'administration de substances chimiques et des médicaments",
"code": {
"@type": "MedicalCode",
"code": "D004333",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.319.267"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Administration par voie buccale",
"alternateName": "Administration, Buccal",
"url": "https://questionsmedicales.fr/mesh/D000278",
"about": {
"@type": "MedicalCondition",
"name": "Administration par voie buccale",
"code": {
"@type": "MedicalCode",
"code": "D000278",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.319.267.120.040"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Administration par voie cutanée",
"alternateName": "Administration, Cutaneous",
"url": "https://questionsmedicales.fr/mesh/D000279",
"about": {
"@type": "MedicalCondition",
"name": "Administration par voie cutanée",
"code": {
"@type": "MedicalCode",
"code": "D000279",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.319.267.120.060"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Administration par voie vaginale",
"alternateName": "Administration, Intravaginal",
"url": "https://questionsmedicales.fr/mesh/D000282",
"about": {
"@type": "MedicalCondition",
"name": "Administration par voie vaginale",
"code": {
"@type": "MedicalCode",
"code": "D000282",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.319.267.120.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Administration par voie vésicale",
"alternateName": "Administration, Intravesical",
"url": "https://questionsmedicales.fr/mesh/D000283",
"about": {
"@type": "MedicalCondition",
"name": "Administration par voie vésicale",
"code": {
"@type": "MedicalCode",
"code": "D000283",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.319.267.120.505"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Administration par voie muqueuse",
"alternateName": "Administration, Mucosal",
"url": "https://questionsmedicales.fr/mesh/D058956",
"about": {
"@type": "MedicalCondition",
"name": "Administration par voie muqueuse",
"code": {
"@type": "MedicalCode",
"code": "D058956",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.319.267.120.655"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Administration par voie nasale",
"alternateName": "Administration, Intranasal",
"url": "https://questionsmedicales.fr/mesh/D000281",
"about": {
"@type": "MedicalCondition",
"name": "Administration par voie nasale",
"code": {
"@type": "MedicalCode",
"code": "D000281",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.319.267.120.655.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Administration par voie rectale",
"alternateName": "Administration, Rectal",
"url": "https://questionsmedicales.fr/mesh/D000285",
"about": {
"@type": "MedicalCondition",
"name": "Administration par voie rectale",
"code": {
"@type": "MedicalCode",
"code": "D000285",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.319.267.120.655.750"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Administration par voie ophtalmique",
"alternateName": "Administration, Ophthalmic",
"url": "https://questionsmedicales.fr/mesh/D060433",
"about": {
"@type": "MedicalCondition",
"name": "Administration par voie ophtalmique",
"code": {
"@type": "MedicalCode",
"code": "D060433",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.319.267.120.805"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Administration par voie topique",
"alternateName": "Administration, Topical",
"code": {
"@type": "MedicalCode",
"code": "D000287",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Cristina Hernández",
"url": "https://questionsmedicales.fr/author/Cristina%20Hern%C3%A1ndez",
"affiliation": {
"@type": "Organization",
"name": "Diabetes and Metabolism Research Unit. Vall d'Hebron Research Institute (VHIR) and Autonomous University of Barcelona (UAB), 08035 Barcelona, Spain."
}
},
{
"@type": "Person",
"name": "Patricia Bogdanov",
"url": "https://questionsmedicales.fr/author/Patricia%20Bogdanov",
"affiliation": {
"@type": "Organization",
"name": "Diabetes and Metabolism Research Unit. Vall d'Hebron Research Institute (VHIR) and Autonomous University of Barcelona (UAB), 08035 Barcelona, Spain."
}
},
{
"@type": "Person",
"name": "Hugo Ramos",
"url": "https://questionsmedicales.fr/author/Hugo%20Ramos",
"affiliation": {
"@type": "Organization",
"name": "Diabetes and Metabolism Research Unit. Vall d'Hebron Research Institute (VHIR) and Autonomous University of Barcelona (UAB), 08035 Barcelona, Spain."
}
},
{
"@type": "Person",
"name": "Olga Simó-Servat",
"url": "https://questionsmedicales.fr/author/Olga%20Sim%C3%B3-Servat",
"affiliation": {
"@type": "Organization",
"name": "Diabetes and Metabolism Research Unit. Vall d'Hebron Research Institute (VHIR) and Autonomous University of Barcelona (UAB), 08035 Barcelona, Spain."
}
},
{
"@type": "Person",
"name": "Rafael Simó",
"url": "https://questionsmedicales.fr/author/Rafael%20Sim%C3%B3",
"affiliation": {
"@type": "Organization",
"name": "Diabetes and Metabolism Research Unit. Vall d'Hebron Research Institute (VHIR) and Autonomous University of Barcelona (UAB), 08035 Barcelona, Spain."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Delivery of biologics: Topical administration.",
"datePublished": "2023-09-04",
"url": "https://questionsmedicales.fr/article/37690380",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.biomaterials.2023.122312"
}
},
{
"@type": "ScholarlyArticle",
"name": "Topical administration of S. salivarius 24SMB-S. oralis 89a in children with adenoidal disease: a double-blind controlled trial.",
"datePublished": "2023-10-24",
"url": "https://questionsmedicales.fr/article/37874401",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00431-023-05192-w"
}
},
{
"@type": "ScholarlyArticle",
"name": "Pharmacokinetic Profile of Brepocitinib with Topical Administration in Atopic Dermatitis and Psoriasis Populations: Strategy to Inform Clinical Trial Design in Adult and Pediatric Populations.",
"datePublished": "2024-03-22",
"url": "https://questionsmedicales.fr/article/38519816",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s11095-024-03654-w"
}
},
{
"@type": "ScholarlyArticle",
"name": "Effect of topical",
"datePublished": "2023-11-13",
"url": "https://questionsmedicales.fr/article/39220605",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.12688/f1000research.131344.2"
}
},
{
"@type": "ScholarlyArticle",
"name": "Topical bromfenac in VEGF-driven maculopathies: topical review and meta-analysis.",
"datePublished": "2024-08-23",
"url": "https://questionsmedicales.fr/article/39180057",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12886-024-03650-z"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Thérapeutique",
"item": "https://questionsmedicales.fr/mesh/D013812"
},
{
"@type": "ListItem",
"position": 3,
"name": "Traitement médicamenteux",
"item": "https://questionsmedicales.fr/mesh/D004358"
},
{
"@type": "ListItem",
"position": 4,
"name": "Voies d'administration de substances chimiques et des médicaments",
"item": "https://questionsmedicales.fr/mesh/D004333"
},
{
"@type": "ListItem",
"position": 5,
"name": "Administration par voie topique",
"item": "https://questionsmedicales.fr/mesh/D000287"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Administration par voie topique - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Administration par voie topique",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-05-11",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Administration par voie topique",
"description": "Comment diagnostiquer une dermatite ?\nQuels tests pour une infection cutanée ?\nQuels signes indiquent une allergie cutanée ?\nComment évaluer une plaie infectée ?\nQuels critères pour une évaluation dermatologique ?",
"url": "https://questionsmedicales.fr/mesh/D000287#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Administration par voie topique",
"description": "Quels sont les symptômes d'une mycose cutanée ?\nComment reconnaître une irritation cutanée ?\nQuels symptômes d'une infection par virus ?\nQuels signes d'une réaction allergique ?\nQuels symptômes d'eczéma ?",
"url": "https://questionsmedicales.fr/mesh/D000287#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Administration par voie topique",
"description": "Comment prévenir les infections cutanées ?\nQuelles mesures pour éviter l'eczéma ?\nComment prévenir les mycoses ?\nQuelles précautions pour les allergies cutanées ?\nComment éviter les irritations cutanées ?",
"url": "https://questionsmedicales.fr/mesh/D000287#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Administration par voie topique",
"description": "Quels traitements pour l'eczéma ?\nComment traiter une infection cutanée ?\nQuels médicaments pour les mycoses ?\nComment soulager une irritation cutanée ?\nQuels traitements pour les brûlures légères ?",
"url": "https://questionsmedicales.fr/mesh/D000287#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Administration par voie topique",
"description": "Quelles complications des infections cutanées ?\nQuels risques d'une mauvaise application topique ?\nQuelles complications de l'eczéma ?\nQuels dangers des traitements inappropriés ?\nQuelles complications des mycoses non traitées ?",
"url": "https://questionsmedicales.fr/mesh/D000287#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Administration par voie topique",
"description": "Quels facteurs de risque pour l'eczéma ?\nQuels risques liés à l'humidité pour la peau ?\nComment le stress influence-t-il la peau ?\nQuels facteurs de risque pour les infections cutanées ?\nQuels sont les risques liés à l'utilisation de produits irritants ?",
"url": "https://questionsmedicales.fr/mesh/D000287#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une dermatite ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'examen clinique et l'historique des symptômes."
}
},
{
"@type": "Question",
"name": "Quels tests pour une infection cutanée ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des prélèvements cutanés et des cultures peuvent être réalisés pour identifier l'infection."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une allergie cutanée ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Rougeurs, démangeaisons et éruptions cutanées sont des signes courants d'allergie."
}
},
{
"@type": "Question",
"name": "Comment évaluer une plaie infectée ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'évaluation inclut l'examen de la rougeur, du gonflement et de l'écoulement."
}
},
{
"@type": "Question",
"name": "Quels critères pour une évaluation dermatologique ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les critères incluent l'apparence, la localisation et l'évolution des lésions cutanées."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une mycose cutanée ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent démangeaisons, rougeurs et desquamation de la peau."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une irritation cutanée ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Rougeur, chaleur et démangeaisons sont des signes d'irritation cutanée."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'une infection par virus ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent inclure des vésicules, des démangeaisons et des douleurs."
}
},
{
"@type": "Question",
"name": "Quels signes d'une réaction allergique ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éruptions cutanées, démangeaisons et gonflement sont des signes d'allergie."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'eczéma ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'eczéma se manifeste par des démangeaisons, des rougeurs et des plaques sèches."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections cutanées ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Maintenir une bonne hygiène et éviter les blessures cutanées aide à prévenir les infections."
}
},
{
"@type": "Question",
"name": "Quelles mesures pour éviter l'eczéma ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les irritants et hydrater régulièrement la peau peut prévenir l'eczéma."
}
},
{
"@type": "Question",
"name": "Comment prévenir les mycoses ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Gardez la peau sèche et évitez les environnements humides pour prévenir les mycoses."
}
},
{
"@type": "Question",
"name": "Quelles précautions pour les allergies cutanées ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Identifiez et évitez les allergènes connus pour prévenir les réactions cutanées."
}
},
{
"@type": "Question",
"name": "Comment éviter les irritations cutanées ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utilisez des produits doux et évitez les frottements pour réduire les irritations."
}
},
{
"@type": "Question",
"name": "Quels traitements pour l'eczéma ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des crèmes hydratantes et des corticostéroïdes topiques."
}
},
{
"@type": "Question",
"name": "Comment traiter une infection cutanée ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antibiotiques topiques ou oraux sont souvent prescrits pour les infections cutanées."
}
},
{
"@type": "Question",
"name": "Quels médicaments pour les mycoses ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antifongiques topiques ou oraux sont utilisés pour traiter les mycoses cutanées."
}
},
{
"@type": "Question",
"name": "Comment soulager une irritation cutanée ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des crèmes apaisantes et des antihistaminiques peuvent aider à soulager l'irritation."
}
},
{
"@type": "Question",
"name": "Quels traitements pour les brûlures légères ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les gels apaisants et les pansements hydrocolloïdes sont recommandés pour les brûlures légères."
}
},
{
"@type": "Question",
"name": "Quelles complications des infections cutanées ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les infections cutanées peuvent entraîner des abcès, des cellulites ou des septicémies."
}
},
{
"@type": "Question",
"name": "Quels risques d'une mauvaise application topique ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une application incorrecte peut aggraver l'état cutané ou provoquer des effets secondaires."
}
},
{
"@type": "Question",
"name": "Quelles complications de l'eczéma ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'eczéma peut entraîner des infections secondaires et des cicatrices cutanées."
}
},
{
"@type": "Question",
"name": "Quels dangers des traitements inappropriés ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'utilisation de traitements inappropriés peut aggraver les symptômes ou causer des allergies."
}
},
{
"@type": "Question",
"name": "Quelles complications des mycoses non traitées ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les mycoses non traitées peuvent se propager et causer des infections systémiques."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour l'eczéma ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents familiaux, les allergies et l'exposition à des irritants augmentent le risque."
}
},
{
"@type": "Question",
"name": "Quels risques liés à l'humidité pour la peau ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une exposition prolongée à l'humidité favorise les infections fongiques et bactériennes."
}
},
{
"@type": "Question",
"name": "Comment le stress influence-t-il la peau ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress peut aggraver les affections cutanées comme l'eczéma et le psoriasis."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour les infections cutanées ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les blessures, l'hygiène insuffisante et les maladies chroniques augmentent le risque."
}
},
{
"@type": "Question",
"name": "Quels sont les risques liés à l'utilisation de produits irritants ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'utilisation de produits agressifs peut provoquer des irritations et des allergies cutanées."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 29/04/2026
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
Diabetes and Metabolism Research Unit. Vall d'Hebron Research Institute (VHIR) and Autonomous University of Barcelona (UAB), 08035 Barcelona, Spain.
Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders (CIBERdem), ISCIII, 28029 Madrid, Spain.
Publications dans "Administration par voie topique" :
3 publications dans cette catégorie
Affiliations :
Diabetes and Metabolism Research Unit. Vall d'Hebron Research Institute (VHIR) and Autonomous University of Barcelona (UAB), 08035 Barcelona, Spain.
Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders (CIBERdem), ISCIII, 28029 Madrid, Spain.
Publications dans "Administration par voie topique" :
3 publications dans cette catégorie
Affiliations :
Diabetes and Metabolism Research Unit. Vall d'Hebron Research Institute (VHIR) and Autonomous University of Barcelona (UAB), 08035 Barcelona, Spain.
Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders (CIBERdem), ISCIII, 28029 Madrid, Spain.
Publications dans "Administration par voie topique" :
3 publications dans cette catégorie
Affiliations :
Diabetes and Metabolism Research Unit. Vall d'Hebron Research Institute (VHIR) and Autonomous University of Barcelona (UAB), 08035 Barcelona, Spain.
Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders (CIBERdem), ISCIII, 28029 Madrid, Spain.
Publications dans "Administration par voie topique" :
3 publications dans cette catégorie
Affiliations :
Diabetes and Metabolism Research Unit. Vall d'Hebron Research Institute (VHIR) and Autonomous University of Barcelona (UAB), 08035 Barcelona, Spain.
Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders (CIBERdem), ISCIII, 28029 Madrid, Spain.
Publications dans "Administration par voie topique" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, Lund University, SE-22100 Lund, Sweden; CSGI, Consorzio Interuniversitario per lo Sviluppo dei Sistemi a Grande Interfase, via della Lastruccia 3, Sesto Fiorentino, Florence I-50019, Italy; Department of Chemical and Geological Sciences, University of Cagliari, s.s 554 bivio Sestu, Monserrato I-09042, Italy. Electronic address: marco.fornasier@fkem1.lu.se.
Publications dans "Administration par voie topique" :
2 publications dans cette catégorie
Affiliations :
Department of Life and Environmental Sciences, University of Cagliari, via Ospedale 72, Cagliari I-09124, Italy.
Publications dans "Administration par voie topique" :
2 publications dans cette catégorie
Affiliations :
Department of Life and Environmental Sciences, University of Cagliari, via Ospedale 72, Cagliari I-09124, Italy.
Publications dans "Administration par voie topique" :
2 publications dans cette catégorie
Affiliations :
CSGI, Consorzio Interuniversitario per lo Sviluppo dei Sistemi a Grande Interfase, via della Lastruccia 3, Sesto Fiorentino, Florence I-50019, Italy; Department of Life and Environmental Sciences, University of Cagliari, via Ospedale 72, Cagliari I-09124, Italy. Electronic address: murgias@unica.it.
Publications dans "Administration par voie topique" :
2 publications dans cette catégorie
Affiliations :
Department of Pharmaceutical Sciences, School of Pharmacy, University of Texas at El Paso, El Paso, Texas 79902, United States.
Border Biomedical Research Center, University of Texas at El Paso, El Paso, Texas 79956, United States.
Biomedical Engineering, and Aerospace Center, College of Engineering, University of Texas at El Paso, El Paso, Texas 79956, United States.
Biomedical Engineering, and Aerospace Center, College of Engineering, University of Texas at El Paso, El Paso, Texas 79956, United States.
Publications dans "Administration par voie topique" :
2 publications dans cette catégorie
Affiliations :
Department of Pharmacy, Faculty of Health Sciences, Institute of Biomedical Sciences, Cardenal Herrera-CEU University, CEU Universities, C/Santiago Ramón y Cajal, s/n., Alfara del Patriarca, 46115 Valencia, Spain.
Publications dans "Administration par voie topique" :
2 publications dans cette catégorie
Affiliations :
Department of Pharmacy, Faculty of Health Sciences, Institute of Biomedical Sciences, Cardenal Herrera-CEU University, CEU Universities, C/Santiago Ramón y Cajal, s/n., Alfara del Patriarca, 46115 Valencia, Spain.
Publications dans "Administration par voie topique" :
2 publications dans cette catégorie
Affiliations :
Department of Pharmacy, Faculty of Health Sciences, Institute of Biomedical Sciences, Cardenal Herrera-CEU University, CEU Universities, C/Santiago Ramón y Cajal, s/n., Alfara del Patriarca, 46115 Valencia, Spain. Electronic address: alopez@uchceu.es.
Publications dans "Administration par voie topique" :
2 publications dans cette catégorie
Affiliations :
Xi'an People's Hospital (Xi'an Fourth Hospital), Shanxi Eye Hospital, Xi'an, Shanxi, China.
Publications dans "Administration par voie topique" :
2 publications dans cette catégorie
Affiliations :
Department of Ophthalmology, Qilu Hospital of Shandong University, Jinan, Shandong, China.
Publications dans "Administration par voie topique" :
2 publications dans cette catégorie
Affiliations :
Department of Ophthalmology, Qilu Hospital of Shandong University, Jinan, Shandong, China.
Publications dans "Administration par voie topique" :
2 publications dans cette catégorie
Affiliations :
Department of Ophthalmology, Qilu Hospital of Shandong University, Jinan, Shandong, China.
Publications dans "Administration par voie topique" :
2 publications dans cette catégorie
Affiliations :
Department of Ophthalmology, Harvard Medical School, Schepens Eye Research Institute of Massachusetts Eye and Ear, Boston, MA, United States.
Publications dans "Administration par voie topique" :
2 publications dans cette catégorie
Affiliations :
Department of Ophthalmology, Qilu Hospital of Shandong University, Jinan, Shandong, China.
Publications dans "Administration par voie topique" :
2 publications dans cette catégorie
Affiliations :
Department of Ophthalmology, Qilu Hospital of Shandong University, Jinan, Shandong, China.
Publications dans "Administration par voie topique" :
Biologics are unaffordable to a large majority of the global population because of prohibitively expensive fermentation systems, purification and the requirement for cold chain for storage and transpo...
Chronic adenoiditis (CA) is generally sustained by some infectious foci mainly located within the nasopharynx or in the deep adenoidal pads and it is characterized by a complex interplay between bacte...
Our findings document a positive effect of Rinogermina spray in achieving reduction in the blockage of nasopharynx space by hypertrophic adenoids, thus suggesting that its use into the integrated ther...
• Chronic adenoiditis in children results from an imablance in baterial homeostasis at the nasophaynx, with impairment in respiratory microbiota. • The modulatory effect of target transnasal bacteriot...
• This randomized controlled study, specifically designed on a cohrt of children with chronic adenoiditis, documents a certain effectiveness of the probiotic treatment in achieving a reduction in the ...
Topical brepocitinib, a tyrosine kinase (TYK)2/Janus kinase (JAK)1 inhibitor, is in development for psoriasis (PsO) and atopic dermatitis (AD). Quantitative analyses of prior clinical trial data were ...
Two phase 2b studies in patients with AD and PsO were used to characterize the amount of topical brepocitinib and the resultant systemic trough concentration (C...
Data from 256 patients were analyzed. Patient type, dose strength, and frequency had significant impacts on the dose-exposure relationship. Systemic concentration in patients with PsO was predicted to...
The relationship between the amount of active drug applied and brepocitinib systemic C...
Plai or...
A RCT was conducted in patients with PDN during February to March 2019. All participants received oral gabapentin 300 mg before bed as a standard regimen. The intervention group (n=16) received Plai b...
At the end of week two and week four, the Plai group showed statistically significant lesser mean pain scores than the placebo group by -1.47 (95%CI: -1.96 to -1.30, p-value < 0.001), and by -1.51 (95...
Registered with the Thai Clinical Trials Registry; TCTR20200221001....
Topical non-steroidal anti-inflammatory drugs have the potential to reduce treatment burden and improve outcomes of anti-VEGF therapy for a number of retinal disorders, including neovascular age-relat...
Cochrane Library, PubMed, and EMBASE were systematically reviewed to identify the relevant studies of neovascular age-related macular degeneration, diabetic macular edema, macular edema associated wit...
In total, ten studies evaluating bromfenac as an adjunct to anti-VEGF therapy were identified. Five studies were included in meta-analysis of the number of injections and five studies were included in...
This literature review and meta-analysis showed that topical bromfenac can be considered as a safe adjunct to anti-VEGF therapy with a potential to reduce the treatment burden with anti-VEGF drugs req...
Acne vulgaris is a common skin disease that greatly impacts the quality of life of affected individuals. Several treatment modalities are available for acne, with variable degrees of success. Our aim ...
A successfully developed topical botulinum toxin product would overcome the disadvantages of injectable administration commonly seen with all available botulinum products, including the potential pain...
Identify the disadvantages of injectable administration of botulinum products and advantages of topical administration. Identify previous attempts to develop topical products and review the only topic...
A literature review regarding injectable botulinum products and topical botulinum product candidates and an analysis of data regarding EMX development were performed....
Multiple disadvantages of injectable administration and advantages of topical administration of botulinum toxin were identified. If available, topical botulinum products are expected to expand the cli...
The development of a topical botulinum toxin is appealing because it overcomes multiple disadvantages observed with injectable administration and would likely result in increased clinical use of botul...
Topical therapy plays an important role in the treatment of psoriasis. It is the gold standard in mild psoriasis cases and is also recommended in addition to UV and systemic therapy in cases of modera...
Eyebrows are an important feature of facial identity and communications in human beings as well as an important eye defense shield from dust and foreign bodies. To compare the efficacy and safety betw...
To compare the efficacy of gauze soaked with combined tranexamic acid (TXA) (100 mg/ml) epinephrine 1:200,000 versus gauze soaked with only epinephrine 1:200,000 used to guard against intraoperative b...
The study included 33 patients; only 30 patients fulfilled the inclusion criteria and were divided randomly into 2 groups using the random numbers table, with 15 patients in each group. The first grou...
The amount of bleeding was significantly lower in group A (29.4 ± 17.1 ml) compared to group B (49.1 ± 18.1 ml), with a P value = 0.005. In addition, the number of used gauzes and total surgical time ...
External DCR using gauze soaked with combined TXA (100 mg/ml) and epinephrine 1:200,000 showed a significant reduction in the amount of intraoperative bleeding compared to gauze soaked with epinephrin...